These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4100727)

  • 1. Response and survival in advanced carcinoma without severe antitumor drug toxicity.
    Savlov ED; Sherman CD; Hall TC; Nahhas WA
    Dis Colon Rectum; 1970; 13(6):421-4. PubMed ID: 4100727
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluorouracil as an adjuvant to surgery in carcinoma of the colon.
    Higgins GA; Dwight RW; Smith JV; Keehn RJ
    Arch Surg; 1971 Apr; 102(4):339-43. PubMed ID: 4101734
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous hyperalimentation as an adjunct to cancer chemotherapy with 5-fluorouracil.
    Souchon EA; Copeland EM; Watson P; Dudrick SJ
    J Surg Res; 1975 Apr; 18(4):451-4. PubMed ID: 806746
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer.
    Falkson G; van Eden EB; Falkson HC
    Cancer; 1974 May; 33(5):1207-9. PubMed ID: 4595974
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitumor drug toxicity: implications for response and for survival.
    Nahhas WA; Hall TC; Sherman CD; Savlov ED
    Am J Med Sci; 1969 Oct; 258(4):245-59. PubMed ID: 5823461
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxicity and antitumor effect of 5-fluorouracil and its rescue by uridine.
    Peters GJ; van Dijk J; van Groeningen C; Laurensse EJ; Leyva A; Lankelma J; Pinedo HM
    Adv Exp Med Biol; 1986; 195 Pt B():121-8. PubMed ID: 2945404
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systemic palliative chemotherapy with 5-fluorouracil and leucovorin in disseminated colorectal cancer].
    Wiboltt K; Raskov HH
    Ugeskr Laeger; 1999 Jun; 161(25):3827-32. PubMed ID: 10412300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allopurinol modulation of high-dose fluorouracil toxicity.
    Tisman G; Wu SJ
    Lancet; 1979 Jun; 1(8130):1353-4. PubMed ID: 87818
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation as palliative therapy of combination chemotherapy with continuous infusional 5-fluorouracil and consecutive low-dose cisplatin in unresectable gastrointestinal carcinoma].
    Yasumoto K; Takeda J; Iwamoto M; Kawabata S; Takeuchi K; Yunoki T Miwa K; Iwakuma N; Shirouzu K
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1909-14. PubMed ID: 9797813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
    Petrelli N; Herrera L; Rustum Y; Burke P; Creaven P; Stulc J; Emrich LJ; Mittelman A
    J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimen.
    Streit M; Jaehde U; Stremetzne S; Ridwelski K; Kerz H; Strohbach F; Hohenberger P; Zwiebel FM; Hebart H; Böthig R; Kairies M; Zillig D; Schuchmann S; Warnecke S; Thiel E; Kreuser ED
    Ann Oncol; 1997 Nov; 8(11):163-5. PubMed ID: 9426339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of fluorouracil on survival in metastatic colorectal cancer fluorouracil response improves survival.
    Payne JE; Pheils MT; Chapuis PH; MacPherson JG
    Aust N Z J Surg; 1981 Feb; 51(1):12-6. PubMed ID: 7013747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-look operation for colon carcinoma after fluorouracil therapy.
    Mackman S; Curreri AR; Ansfield FJ
    Arch Surg; 1970 Apr; 100(4):527-31. PubMed ID: 4190476
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of 5-fluorouracil in mice using uridine diphosphoglucose.
    Codacci-Pisanelli G; Kralovanszky J; van der Wilt CL; Noordhuis P; Colofiore JR; Martin DS; Franchi F; Peters GJ
    Clin Cancer Res; 1997 Feb; 3(2):309-15. PubMed ID: 9815688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brequinar potentiates 5-fluorouracil antitumor activity in a murine model colon 38 tumor by tissue-specific modulation of uridine nucleotide pools.
    Pizzorno G; Wiegand RA; Lentz SK; Handschumacher RE
    Cancer Res; 1992 Apr; 52(7):1660-5. PubMed ID: 1551097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy for advanced colorectal cancer with a combination of 5-FU and anguidine: a Southwest Oncology Group Study.
    Goodwin W; Stephens R; McCracken JD; Groppe C
    Cancer Treat Rep; 1981; 65(3-4):359. PubMed ID: 7237462
    [No Abstract]   [Full Text] [Related]  

  • 17. The second look operation for carcinoma of the colon after administration of 5-fluorouracil.
    Mackman S; Curreri AR
    Am J Surg; 1968 Feb; 115(2):227-30. PubMed ID: 4169688
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemo-biotherapy with 5-fluorouracil, leucovorin, and alpha interferon in metastatic carcinoma of the colon--a Cancer Biotherapy Research Group [CBRG] phase II study.
    Soori GS; Oldham RK; Dobbs TW; Bury MJ; Church CK; DePriest C
    Cancer Biother Radiopharm; 2000 Apr; 15(2):175-83. PubMed ID: 10803323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy after palliative resection of colorectal cancer. Yorkshire Gastrointestinal Tumour Group.
    Br J Surg; 1984 Apr; 71(4):283-6. PubMed ID: 6200173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose intermittent iv 5-FU and melphalan in advanced colorectal carcinoma.
    Gough IR; Furnival CM
    Cancer Treat Rep; 1983 Jun; 67(6):595-6. PubMed ID: 6344994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.